Haemonetics (HAE) Enterprise Value (2009 - 2026)

Haemonetics' Enterprise Value history runs 18 years deep, the most recent figure standing at -$245.4 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 19.99% year-over-year to -$245.4 million; the TTM figure through Mar 2026 stood at -$245.4 million (up 19.99% YoY), while the FY2026 annual figure was -$245.4 million, up 19.99% from the prior year.
• Enterprise Value was -$245.4 million for Q1 2026 at Haemonetics, up from -$363.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$178.8 million in Q1 2024 to a low of -$363.4 million in Q4 2025.
• Historically, Enterprise Value has averaged -$274.4 million across 5 years, with a median of -$285.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 37.15% in 2024, then plunged 71.57% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$224.0 million in 2022, then rose by 13.4% to -$194.0 million in 2023, then plunged by 65.4% to -$320.8 million in 2024, then fell by 13.25% to -$363.4 million in 2025, then soared by 32.45% to -$245.4 million in 2026.
• The last three Enterprise Value figures came in at -$245.4 million (Q1 2026), -$363.4 million (Q4 2025), and -$296.4 million (Q3 2025), per Business Quant data.